 |
|
|
| |
EPP
Introduction
Erythropoietic protoporphyria is a disease of porphyrin metabolism
characterized by abnormally elevated levels of protoporphyrin IX
in erythocytes (mature blood cells), feces and plasma (the fluid
portion of circulating blood), and by sensitivity to visible light.
This sensitivity manifests itself as a burning sensation in the
skin, followed by varying degrees of erythema (redness of the skin
due to capillary dialation) and edema (swelling caused by excess
fluids). Consequently, patients with the disorder commonly avoid
exposure of the skin to strong light. They tend to choose indoor
occupations, nocturnal work, or to venture outdoors while heavily
clothed to protect the skin.
|
|
|
|
| |
|
The APF is not responsible for the interpretive translations in other languages.
The information contained on the American Porphyria Foundation (APF) Web
site or in the APF newsletter is provided for your general information only.
The APF does not give medical advice or engage in the practice of medicine.
The APF under no circumstances recommends particular treatments for specific
individuals, and in all cases recommends that you consult your physician or
local treatment center before pursuing any course of treatment.
All information and content on this Web site are protected by copyright. All
rights are reserved. Users are prohibited from modifying, copying,
distributing, transmitting, displaying, publishing, selling, licensing,
creating derivative works, or using any information available on or through
the site for commercial or public purposes.
The American Porphyria Foundation (APF) Tax Forms 990 are readily available to the public. If you would like a copy, please contact the APF: 4900 Woodway, Suite 780, Houston, TX 77056. Toll free: 1.866.APF.3635.
Join the APF—Your
donations help support patient and physician education as
well as porphyria research. Learn
more...
© 2007 American Porphyria Foundation.
All Rights Reserved. |
|
|